Rod Gerardo and Ellen Ancisco

60 timestamped statements across 3 collections — auto-found in recorded discussions, each timestamp jumps to the exact moment.

Featured diaries

▶ Ep 25 · 8:02
The presence of hydrops is the strongest prognostic indicator of mortality in these patients.
quote · Congenital Lung Lesions (CPAM)
▶ Ep 25 · 8:02
The presence of hydrops is the strongest prognostic indicator of mortality in these patients.
quote · Congenital Lung Lesions (CPAM)
▶ Ep 19 · 8:02
The presence of hydrops is the strongest prognostic indicator of mortality in these patients.
quote · Congenital Pulmonary Airway Malformation
▶ Ep 17 · 8:02
The presence of hydrops is the strongest prognostic indicator of mortality in these patients.
quote · Fetal Surgery
▶ Ep 19 · 25:29
The main reasons for operating on asymptomatic CPAMs are: risk of malignancy both at resection and from malignant transformation later, risk of infection that will make surgery more difficult, and better compensatory lung growth if operating sooner in life.
host_summary · Congenital Pulmonary Airway Malformation
▶ Ep 17 · 25:29
The main reasons for operating on asymptomatic CPAMs are: risk of malignancy both at resection and from malignant transformation later, risk of infection that will make surgery more difficult, and better compensatory lung growth if operating sooner in life.
opinion · Fetal Surgery

Nothing matches these filters — clear the search or widen the filters.

Congenital Lung Lesions (CPAM) 30 entries

The Full Story on CPAMs

▶ Ep 25 · 5:12
host_summary The Stocker classification for CPAMs ranges from type 0 to type 4, moving from proximal to distal in the bronchial tree, with type 1 (distal bronchi/proximal bronchioles) being most common at 60-70% of cases. ↗
▶ Ep 25 · 5:12
clinical The Stocker classification for CPAMs ranges from type 0 to type 4, moving from proximal to distal in the bronchial tree, with type 1 (distal bronchi/proximal bronchioles) being most common at 60-70% of cases. ↗
▶ Ep 25 · 6:57
clinical CPAMs typically grow during the first 20-25 weeks of gestation and plateau around week 28. ↗
▶ Ep 25 · 6:57
host_summary CPAMs typically grow during the first 20-25 weeks of gestation and plateau around week 28. ↗
▶ Ep 25 · 8:02
clinical The presence of hydrops is the strongest prognostic indicator of mortality in fetuses with CPAMs. ↗
▶ Ep 25 · 8:02
host_summary The presence of hydrops is the strongest prognostic indicator of mortality in fetuses with CPAMs. ↗
▶ Ep 25 · 8:02
quote The presence of hydrops is the strongest prognostic indicator of mortality in these patients. ↗
▶ Ep 25 · 8:02
quote The presence of hydrops is the strongest prognostic indicator of mortality in these patients. ↗
▶ Ep 25 · 8:41
clinical The CPAM volume ratio (CVR) is calculated as the CPAM's length times width times height times 0.52 divided by the head circumference. ↗
▶ Ep 25 · 8:41
host_summary The CPAM volume ratio (CVR) is calculated as the CPAM's length times width times height times 0.52 divided by the head circumference. ↗
▶ Ep 25 · 9:14
host_summary In patients with CVR over 1.6, it is estimated that 75% develop hydrops. ↗
▶ Ep 25 · 9:14
epidemiological In patients with CVR over 1.6, it is estimated that 75% develop hydrops. ↗
▶ Ep 25 · 10:14
clinical CPAMs are differentiated as microcystic (less than 5 millimeters) or macrocystic (larger than 5 millimeters). ↗
▶ Ep 25 · 10:14
host_summary CPAMs are differentiated as microcystic (less than 5 millimeters) or macrocystic (larger than 5 millimeters). ↗
▶ Ep 25 · 22:25
host_summary CPAMs are not well-visualized on chest X-rays and can regress or get smaller over time. ↗
▶ Ep 25 · 22:25
clinical CPAMs are not well-visualized on chest X-rays and can regress or get smaller over time. ↗
▶ Ep 25 · 24:40
clinical In the United States, most surgeons resect CPAMs even if asymptomatic, while in Europe and Canada, surgeons sometimes choose to monitor asymptomatic lesions and avoid surgery. ↗
▶ Ep 25 · 24:40
host_summary In the United States, most surgeons resect CPAMs even if asymptomatic, while in Europe and Canada, surgeons sometimes choose to monitor asymptomatic lesions and avoid surgery. ↗
▶ Ep 25 · 25:29
opinion The main reasons for operating on asymptomatic CPAMs are: risk of malignancy both at resection and from malignant transformation later, risk of infection that will make surgery more difficult, and better compensatory lung growth if operating sooner in life. ↗
▶ Ep 25 · 25:29
host_summary The main reasons for operating on asymptomatic CPAMs are: risk of malignancy both at resection and from malignant transformation later, risk of infection that will make surgery more difficult, and better compensatory lung growth if operating sooner in life. ↗
▶ Ep 25 · 26:03
host_summary Thoracoscopic lobectomy risks include bleeding, prolonged post-op mechanical ventilation, infections, air leak, pneumothorax, nerve injury, and mortality. ↗
▶ Ep 25 · 26:03
clinical Thoracoscopic lobectomy risks include bleeding, prolonged post-op mechanical ventilation, infections, air leak, pneumothorax, nerve injury, and mortality. ↗
▶ Ep 25 · 27:47
host_summary The particular malignancy associated with CPAM is pleuropulmonary blastoma (PPB), with risk that the lesion at birth already has malignancy and risk of malignant transformation over a person's life. ↗
▶ Ep 25 · 27:47
clinical The particular malignancy associated with CPAM is pleuropulmonary blastoma (PPB), with risk that the lesion at birth already has malignancy and risk of malignant transformation over a person's life. ↗
▶ Ep 25 · 30:17
host_summary A recent study published in April 2021 found that no prenatally diagnosed lesions had malignancy, but 10% of patients diagnosed postnatally had malignancy in their resected mass. ↗
▶ Ep 25 · 30:17
epidemiological A recent study published in April 2021 found that no prenatally diagnosed lesions had malignancy, but 10% of patients diagnosed postnatally had malignancy in their resected mass. ↗
▶ Ep 25 · 52:39
host_summary The incidence of CPAMs is estimated to be about 1 in every 8,000 to 35,000 births. ↗
▶ Ep 25 · 52:39
epidemiological The incidence of CPAMs is estimated to be about 1 in every 8,000 to 35,000 births. ↗
▶ Ep 25 · 52:53
epidemiological 60% of prenatally diagnosed lung lesions are CPAMs, making them the most common prenatal lung lesion. ↗
▶ Ep 25 · 52:53
host_summary 60% of prenatally diagnosed lung lesions are CPAMs, making them the most common prenatal lung lesion. ↗
Congenital Pulmonary Airway Malformation 15 entries

The Full Story on CPAMs

▶ Ep 19 · 5:12
host_summary The Stocker classification for CPAMs ranges from type 0 to type 4, moving from proximal to distal in the bronchial tree, with type 1 (distal bronchi/proximal bronchioles) being most common at 60-70% of cases. ↗
▶ Ep 19 · 6:57
host_summary CPAMs typically grow during the first 20-25 weeks of gestation and plateau around week 28. ↗
▶ Ep 19 · 8:02
host_summary The presence of hydrops is the strongest prognostic indicator of mortality in fetuses with CPAMs. ↗
▶ Ep 19 · 8:02
quote The presence of hydrops is the strongest prognostic indicator of mortality in these patients. ↗
▶ Ep 19 · 8:41
host_summary The CPAM volume ratio (CVR) is calculated as the CPAM's length times width times height times 0.52 divided by the head circumference. ↗
▶ Ep 19 · 9:14
host_summary In patients with CVR over 1.6, it is estimated that 75% develop hydrops. ↗
▶ Ep 19 · 10:14
host_summary CPAMs are differentiated as microcystic (less than 5 millimeters) or macrocystic (larger than 5 millimeters). ↗
▶ Ep 19 · 22:25
host_summary CPAMs are not well-visualized on chest X-rays and can regress or get smaller over time. ↗
▶ Ep 19 · 24:40
host_summary In the United States, most surgeons resect CPAMs even if asymptomatic, while in Europe and Canada, surgeons sometimes choose to monitor asymptomatic lesions and avoid surgery. ↗
▶ Ep 19 · 25:29
host_summary The main reasons for operating on asymptomatic CPAMs are: risk of malignancy both at resection and from malignant transformation later, risk of infection that will make surgery more difficult, and better compensatory lung growth if operating sooner in life. ↗
▶ Ep 19 · 26:03
host_summary Thoracoscopic lobectomy risks include bleeding, prolonged post-op mechanical ventilation, infections, air leak, pneumothorax, nerve injury, and mortality. ↗
▶ Ep 19 · 27:47
host_summary The particular malignancy associated with CPAM is pleuropulmonary blastoma (PPB), with risk that the lesion at birth already has malignancy and risk of malignant transformation over a person's life. ↗
▶ Ep 19 · 30:17
host_summary A recent study published in April 2021 found that no prenatally diagnosed lesions had malignancy, but 10% of patients diagnosed postnatally had malignancy in their resected mass. ↗
▶ Ep 19 · 52:39
host_summary The incidence of CPAMs is estimated to be about 1 in every 8,000 to 35,000 births. ↗
▶ Ep 19 · 52:53
host_summary 60% of prenatally diagnosed lung lesions are CPAMs, making them the most common prenatal lung lesion. ↗
Fetal Surgery 15 entries

The Full Story on CPAMs

▶ Ep 17 · 5:12
clinical The Stocker classification for CPAMs ranges from type 0 to type 4, moving from proximal to distal in the bronchial tree, with type 1 (distal bronchi/proximal bronchioles) being most common at 60-70% of cases. ↗
▶ Ep 17 · 6:57
clinical CPAMs typically grow during the first 20-25 weeks of gestation and plateau around week 28. ↗
▶ Ep 17 · 8:02
clinical The presence of hydrops is the strongest prognostic indicator of mortality in fetuses with CPAMs. ↗
▶ Ep 17 · 8:02
quote The presence of hydrops is the strongest prognostic indicator of mortality in these patients. ↗
▶ Ep 17 · 8:41
clinical The CPAM volume ratio (CVR) is calculated as the CPAM's length times width times height times 0.52 divided by the head circumference. ↗
▶ Ep 17 · 9:14
epidemiological In patients with CVR over 1.6, it is estimated that 75% develop hydrops. ↗
▶ Ep 17 · 10:14
clinical CPAMs are differentiated as microcystic (less than 5 millimeters) or macrocystic (larger than 5 millimeters). ↗
▶ Ep 17 · 22:25
clinical CPAMs are not well-visualized on chest X-rays and can regress or get smaller over time. ↗
▶ Ep 17 · 24:40
clinical In the United States, most surgeons resect CPAMs even if asymptomatic, while in Europe and Canada, surgeons sometimes choose to monitor asymptomatic lesions and avoid surgery. ↗
▶ Ep 17 · 25:29
opinion The main reasons for operating on asymptomatic CPAMs are: risk of malignancy both at resection and from malignant transformation later, risk of infection that will make surgery more difficult, and better compensatory lung growth if operating sooner in life. ↗
▶ Ep 17 · 26:03
clinical Thoracoscopic lobectomy risks include bleeding, prolonged post-op mechanical ventilation, infections, air leak, pneumothorax, nerve injury, and mortality. ↗
▶ Ep 17 · 27:47
clinical The particular malignancy associated with CPAM is pleuropulmonary blastoma (PPB), with risk that the lesion at birth already has malignancy and risk of malignant transformation over a person's life. ↗
▶ Ep 17 · 30:17
epidemiological A recent study published in April 2021 found that no prenatally diagnosed lesions had malignancy, but 10% of patients diagnosed postnatally had malignancy in their resected mass. ↗
▶ Ep 17 · 52:39
epidemiological The incidence of CPAMs is estimated to be about 1 in every 8,000 to 35,000 births. ↗
▶ Ep 17 · 52:53
epidemiological 60% of prenatally diagnosed lung lesions are CPAMs, making them the most common prenatal lung lesion. ↗